Skip to content

Partnerships

Built tocollaborate.

Object Pharma welcomes discussions with pharmaceutical, biotechnology, academic and strategic partners interested in advancing neurotoxin science and therapeutic innovation.

Collaboration areas

P01

Therapeutic development

  • ·Co-development
  • ·Licensing
  • ·Indication partnerships

P02

Scientific collaboration

  • ·Translational research
  • ·Academic collaborations
  • ·Neurotoxin biology

P03

Development capabilities

  • ·Process development
  • ·Specialized neurotoxin expertise
  • ·Selected ecosystem capabilities

P04

Commercial opportunities

  • ·Regional partnerships
  • ·Selected portfolio opportunities
  • ·Medical-aesthetics opportunities through the appropriate Object company
Start the conversation

Contact business development.

Tell us about your organization and the opportunity you would like to explore. Our business development team reviews every inquiry.

By submitting this form, you agree that Object Pharma may use the information you provide to respond to your inquiry. Privacy Policy